Blood Components is a clinical reference app for healthcare professionals that summarizes national transfusion guidelines on iOS.
The App DNA
What makes this app unique?
Clinicians hire the app to ensure compliance with NBTC, BSH, and NICE guidelines during transfusion procedures without navigating multiple paper or web sources.
For Clinicians and healthcare professionals involved in blood transfusion procedures.
What does it look like?
Key features
Summarizes NBTC 2020 indication codes to guide clinical decision-making for blood component usage.
Aggregates BSH 2016 and NICE NG24 transfusion guidelines into a single reference interface.
Provides structured guidance to facilitate accurate clinical record-keeping for blood transfusion indications.
How much does it cost?
The app is a free public service provided by the NHS to support clinical compliance with national guidelines.
Velocity
Maintenance developmentperformanceopaqueShow more...
Blood Components is currently in a maintenance cycle, having shipped only one update in the last six months. This release cadence of approximately 0.04 releases per week indicates a lack of active feature development. The latest version provided no specific feature information, focusing solely on generic bug fixes. There is no evidence of live operations or recurring content updates.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Blood Components
How's the Medical market?
Blood Components serves as a specialized medical utility with no active user rating volume, signaling low visibility within the clinical community. The lack of updates over the last five months confirms a maintenance-only posture.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Blood Components
Where is it heading?
The clinical reference market is shifting toward dynamic, web-integrated tools that update in real-time, leaving static apps like Blood Components increasingly exposed. If the NHS does not shift to an automated update model, the app will lose its utility as a primary clinical reference.
- The latest release focused solely on generic bug fixes, confirming the app remains in a maintenance-only lifecycle phase.
- The absence of active development cycles risks the app becoming obsolete as national transfusion guidelines continue to evolve.
The SWOT
- NHS-backed authority provides a high-trust barrier for clinical adoption
- Aggregation of NICE and BSH guidelines reduces search friction for clinicians
- Integration with electronic patient record systems could shift the app to a workflow-integrated utility
- Expansion of the guideline library to include real-time updates could increase daily utility
Next best moves
Automate guideline update triggers because the current static model risks clinical obsolescence → ensure long-term utility
The counter-intuitive read
The app's lack of consumer-facing features is not…
Read the full takeSince the last report: The app remains in a maintenance phase with no functional updates, but the competitive assessment has sharpened to emphasize the risk of obsolescence against dynamic web-based alternatives.
Bottom line
Blood Components provides a reliable reference for transfusion guidelines, but its static nature and lack of recent updates threaten its long-term relevance, so the NHS should prioritize a transition to a dynamic, web-integrated service to maintain clinical utility.
Unlock 2 critical frictions, 2 market threats and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated